VUKANEOS PHARMA

KBO/BCE: BE 0839.519.855

Loading dossier…

Year closed	Due by	Filed	Variance	Reference
31-12-2025	31-07-2026	nothing on record	not filed	-
31-12-2024	31-07-2025	nothing on record	not filed	-
31-12-2023	31-07-2024	nothing on record	not filed	-
31-12-2022	31-07-2023	30-06-2023	31 d early	2023-00178397
31-12-2021	31-07-2022	30-06-2022	31 d early	2022-20145156
31-12-2020	31-07-2021	30-07-2021	1 d early	2021-45600255
31-12-2019	31-07-2020	14-08-2020	14 d late	2020-41800268
31-12-2018	31-07-2019	28-08-2019	28 d late	2019-56000565
31-12-2017	31-07-2018	29-08-2018	29 d late	2018-58000131
31-12-2016	31-07-2017	31-08-2017	31 d late	2017-56300075
31-12-2015	31-07-2016	04-10-2016	65 d late	2016-64600197
31-12-2014	31-07-2015	09-10-2015	70 d late	2015-64600508

Metric	This company	Sector median	Position in the sector
Solvency	43.1%	55.1%	better than 37% of 6846 sector peers
Net result	€12k	€26k	better than 33% of 6845 sector peers
Equity	€23k	€43k	better than 33% of 6854 sector peers
Gross operating margin	€18k	€43k	better than 28% of 6833 sector peers
Total assets	€53k	€94k	better than 29% of 6847 sector peers

Line item	Code	2022
Balance sheet, Assets
TOTAL ASSETS	20/58	€53k
Current assets	29/58	€53k
Amounts receivable within one year	40/41	€52k
Cash & bank	54/58	€4
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€53k
Equity	10/15	€23k
Contributions / capital	10/11	€19k
Reserves	13	€20k
Accumulated profits (losses)	14	€-16k
Amounts payable	17/49	€30k
Amounts payable within one year	42/48	€30k
Trade debts payable within one year	44	€6k
Income statement
Gross operating margin	9900	€18k
Operating result	9901	€14k
Financial income	75	€2k
Financial charges	65	€616
Result before taxes	9903	€16k
Income taxes	67/77	€4k
Net result for the period	9904	€12k
Result to be appropriated	9905	€12k

Summary